Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...

Danish drug maker Novo Nordisk said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% ...

Progressives blame the free market for insulin prices and want to impose price controls. But, government regulation is to blame.

The rising price of insulin has become one of the most talked about issues across the pharma industry. Ben Hargreaves explains how Eli Lilly decided to cap its insulin price, why it has decided to ...

told lawyers for the state of California that they would have to revise their lawsuit challenging insulin drug prices, sustaining two motions for demurrer filed by drug makers and pharmacy benefit ...

Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions of 70% for its most commonly prescribed insulins, as well as expansion of its Insulin Value Program, capping ...

Novo Nordisk said it will cut the list prices in the U.S. of two of its insulin drugs, Tresiba (insulin degludec) and Fiasp ...

Pharmacy benefit managers and prescription drug manufacturers may have artificially inflated the price of insulin, making this life-saving medication unaffordable for many Americans. Insulin ...

Novo Nordisk (NOV: N) will reduce the US list prices of two insulin products, Tresiba (insulin degludec) and Fiasp (insulin aspart), by over 70% from 2026. The list price reductions will bring Tresiba ...

New Jersey patients deserve access to the best, affordable drugs our high-quality health care system has to offer. PBM reform is essential.